[DOI] [PMC free article] [PubMed] [Google Scholar] Boots J
(PubMed) Stop further injections and report the event to the clinic and your national drug safety authority (e.g., FDA in the US, local health regulator)
The FDA has called out compounded versions of popular GLP-1 drugs, saying theyre risky for patients. Dosing is of particular concern
Beert E, Brems H, Danils B, de Wever I, van Calenbergh F, Schoenaers J, Debiec-Rychter M, Gevaert O, de Raedt T, van den Bruel A, de Ravel T, Cichowski K, Kluwe L, Mautner V, Sciot R, Legius E (2011) Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors
10.1016/j.physbeh.2010.03.019 55 HeppnerK
These are shipped directly to you from FDA-registered and inspected pharmacies